Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
12 p.
- Autores:
-
Lonn, Eva
Bosch, Jackie
Lopez-Jaramillo, Patricio
Zhu, Jun
Liu, Lisheng
Pais, Prem
Diaz, Rafael
Xavier, Denis
Sliwa, Karen
Dans, Antonio
Avezum, Alvaro
Leopoldo S., Piegas
Keltai, Katalin
Keltai, Matyas
Chazova, Irina
Peters, Ron J.G.
Held, Claes
Yusoff, Khalid
Lewis, Basil S.
Jansky, Petr
Parkhomenko, Alexander
Khunti, Kamlesh
Toff, William D.
Reid, Christopher M.
Varigos, John
Leiter, Lawrence A.
Molina, Dora I.
McKelvie, Robert
Pogue, Janice
Wilkinson, Joanne
Jung, Hyejung
Dagenais, Gilles
Yusuf, Salim
HOPE-3 Investigators
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2016
- Institución:
- Universidad de Santander
- Repositorio:
- Repositorio Universidad de Santander
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.udes.edu.co:001/3457
- Acceso en línea:
- https://repositorio.udes.edu.co/handle/001/3457
- Palabra clave:
- Blood pressure
Intermediate risk
Cardiovascular disease
- Rights
- openAccess
- License
- Derechos Reservados - New England Journal of Medicine, 2016
| id |
RUDES2_906cedb1a8d1d98e8979d8fb361c7237 |
|---|---|
| oai_identifier_str |
oai:repositorio.udes.edu.co:001/3457 |
| network_acronym_str |
RUDES2 |
| network_name_str |
Repositorio Universidad de Santander |
| repository_id_str |
|
| dc.title.eng.fl_str_mv |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| title |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| spellingShingle |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease Blood pressure Intermediate risk Cardiovascular disease |
| title_short |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| title_full |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| title_fullStr |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| title_full_unstemmed |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| title_sort |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease |
| dc.creator.fl_str_mv |
Lonn, Eva Bosch, Jackie Lopez-Jaramillo, Patricio Zhu, Jun Liu, Lisheng Pais, Prem Diaz, Rafael Xavier, Denis Sliwa, Karen Dans, Antonio Avezum, Alvaro Leopoldo S., Piegas Keltai, Katalin Keltai, Matyas Chazova, Irina Peters, Ron J.G. Held, Claes Yusoff, Khalid Lewis, Basil S. Jansky, Petr Parkhomenko, Alexander Khunti, Kamlesh Toff, William D. Reid, Christopher M. Varigos, John Leiter, Lawrence A. Molina, Dora I. McKelvie, Robert Pogue, Janice Wilkinson, Joanne Jung, Hyejung Dagenais, Gilles Yusuf, Salim HOPE-3 Investigators |
| dc.contributor.author.spa.fl_str_mv |
Lonn, Eva Bosch, Jackie Lopez-Jaramillo, Patricio Zhu, Jun Liu, Lisheng Pais, Prem Diaz, Rafael Xavier, Denis Sliwa, Karen Dans, Antonio Avezum, Alvaro Leopoldo S., Piegas Keltai, Katalin Keltai, Matyas Chazova, Irina Peters, Ron J.G. Held, Claes Yusoff, Khalid Lewis, Basil S. Jansky, Petr Parkhomenko, Alexander Khunti, Kamlesh Toff, William D. Reid, Christopher M. Varigos, John Leiter, Lawrence A. Molina, Dora I. McKelvie, Robert Pogue, Janice Wilkinson, Joanne Jung, Hyejung Dagenais, Gilles Yusuf, Salim HOPE-3 Investigators |
| dc.subject.proposal.eng.fl_str_mv |
Blood pressure Intermediate risk Cardiovascular disease |
| topic |
Blood pressure Intermediate risk Cardiovascular disease |
| description |
12 p. |
| publishDate |
2016 |
| dc.date.issued.spa.fl_str_mv |
2016-04-26 |
| dc.date.accessioned.spa.fl_str_mv |
2019-07-24T15:45:52Z |
| dc.date.available.spa.fl_str_mv |
2019-07-24T15:45:52Z |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.doi.spa.fl_str_mv |
10.1056/NEJMoa1600175 |
| dc.identifier.issn.spa.fl_str_mv |
1533-4406 0028-4793 |
| dc.identifier.uri.spa.fl_str_mv |
https://repositorio.udes.edu.co/handle/001/3457 |
| identifier_str_mv |
10.1056/NEJMoa1600175 1533-4406 0028-4793 |
| url |
https://repositorio.udes.edu.co/handle/001/3457 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartof.eng.fl_str_mv |
New England Journal of Medicine |
| dc.rights.spa.fl_str_mv |
Derechos Reservados - New England Journal of Medicine, 2016 |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.creativecommons.spa.fl_str_mv |
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ |
| rights_invalid_str_mv |
Derechos Reservados - New England Journal of Medicine, 2016 Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.source.eng.fl_str_mv |
https://www.researchgate.net/publication/299592776_Blood-Pressure_Lowering_in_Intermediate-Risk_Persons_without_Cardiovascular_Disease/link/59d8ac87aca272e60966b4a5/download |
| institution |
Universidad de Santander |
| bitstream.url.fl_str_mv |
https://repositorio.udes.edu.co/bitstreams/2dfdd078-547a-49ed-a199-2bb0dfea746d/download https://repositorio.udes.edu.co/bitstreams/6b90f20d-22af-41b5-a317-795605083901/download https://repositorio.udes.edu.co/bitstreams/3be78a2a-91e0-4a5a-ab0f-9508809adc3b/download https://repositorio.udes.edu.co/bitstreams/7bf7c2bf-4a8b-4a1e-8155-8d3a90f786eb/download |
| bitstream.checksum.fl_str_mv |
6f2b0454df879634c8df8fd9f2bcdddf e6c9fb91069534fe8746cdcd3e97030c d4139a8a1251680824766d09c1a0e5fd 38d94cf55aa1bf2dac1a736ac45c881c |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Universidad de Santander |
| repository.mail.fl_str_mv |
soporte@metabiblioteca.com |
| _version_ |
1814158808881037312 |
| spelling |
Lonn, Eva7a977a4b-14e3-44cc-8057-933d424aaa9b-1Bosch, Jackie503f2202-0dda-463c-acc9-f5888e895278-1Lopez-Jaramillo, Patricio9a71267b-dcb0-4d31-b37d-2d30be58d4d2-1Zhu, Jund97cdbd2-6a82-430c-abfe-c978f085997e-1Liu, Lishenga14adafe-ef37-42b0-8f5b-0de4ea71b0fc-1Pais, Prem5abdbf77-3c3f-4396-8634-83723aa215b9-1Diaz, Rafaelf2be4a74-501a-4e63-8bbd-965cbcf8c57b-1Xavier, Denis88c9cf48-fa3b-45c6-be03-2cc79e59289d-1Sliwa, Karen7ff2b80f-9412-4d65-99cd-7d01d5578687-1Dans, Antoniof365ef5a-7610-4022-8485-31d6d3879cd6-1Avezum, Alvaro8b920360-abb2-4ec8-b5ee-4e3f4e0b11eb-1Leopoldo S., Piegasc7e81282-b4ee-4b25-8b4a-1108cc6aeb25-1Keltai, Kataline6748cb0-125e-4199-9d27-8f14335aec02-1Keltai, Matyas65c5da4f-dca6-4e4f-aa9e-6c2ff81f2df9-1Chazova, Irinace6fc484-15aa-401c-a370-8afcad931907-1Peters, Ron J.G.43007a97-9e31-41a5-a7fc-ce7357bd484f-1Held, Claes76b69ce8-c468-49c5-8d48-95a823d8b565-1Yusoff, Khalid933db13d-f5bb-4ea6-91a5-68eea1ca9ffc-1Lewis, Basil S.a8106b8e-2b4b-412e-90c7-4012b1272405-1Jansky, Petrbf8ec62a-6edc-439c-a698-2e4fa4172f04-1Parkhomenko, Alexander11fab1ea-f0f6-47e0-97e9-36e372b7e2f9-1Khunti, Kamleshe9aff03a-6f97-433d-a56e-8d7f703caa03-1Toff, William D.97acb6df-c33b-45ad-b772-c52ac4aa7281-1Reid, Christopher M.7d8a8211-12ad-464c-948d-16952b66144d-1Varigos, Johnedec3b03-87c5-454c-aec5-b2c04c91a9d9-1Leiter, Lawrence A.bcdd3211-40b7-474d-9f6c-8a1051ceb9bf-1Molina, Dora I.225d863d-6d12-4408-a1de-50047831b3c4-1McKelvie, Robertb7cfc72e-3a56-4797-8848-d0db71a3ef50-1Pogue, Janiceda5c963c-440a-4bf6-981a-f2217b50fc1d-1Wilkinson, Joanne029fd784-e030-4eb6-82ec-11f67a7bcab2-1Jung, Hyejung50f4ceae-59e5-4f12-9788-b713f56de3be-1Dagenais, Gillesc865f015-4dc7-483d-9dae-132288d901f8-1Yusuf, Salim06a836b5-f5e3-41d9-a516-9cc46e5d7948-1HOPE-3 Investigatorsad5cd98d-86e0-4739-a226-91ef50ed152c-12019-07-24T15:45:52Z2019-07-24T15:45:52Z2016-04-2612 p.BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its role in persons at intermediate risk and with lower blood pressure is unclear. METHODS In one comparison from a 2-by-2 factorial trial, we randomly assigned 12,705 participants at intermediate risk who did not have cardiovascular disease to receive either candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day or placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke; the second coprimary outcome additionally included resuscitated cardiac arrest, heart failure, and revascularization. The median follow-up was 5.6 years. RESULTS The mean blood pressure of the participants at baseline was 138.1/81.9 mm Hg; the decrease in blood pressure was 6.0/3.0 mm Hg greater in the active-treatment group than in the placebo group. The first coprimary outcome occurred in 260 participants (4.1%) in the active-treatment group and in 279 (4.4%) in the placebo group (hazard ratio, 0.93; 95% confidence interval [CI], 0.79 to 1.10; P=0.40); the second coprimary outcome occurred in 312 participants (4.9%) and 328 participants (5.2%), respectively (hazard ratio, 0.95; 95% CI, 0.81 to 1.11; P=0.51). In one of the three prespecified hypothesis-based subgroups, participants in the subgroup for the upper third of systolic blood pressure (>143.5 mm Hg) who were in the active-treatment group had significantly lower rates of the first and second coprimary outcomes than those in the placebo group; effects were neutral in the middle and lower thirds (P=0.02 and P=0.009, respectively, for trend in the two outcomes). CONCLUSIONS Therapy with candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day was not associated with a lower rate of major cardiovascular events than placebo among persons at intermediate risk who did not have cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; ClinicalTrials.gov number, NCT00468923.)application/pdf10.1056/NEJMoa16001751533-44060028-4793https://repositorio.udes.edu.co/handle/001/3457engNew England Journal of MedicineDerechos Reservados - New England Journal of Medicine, 2016info:eu-repo/semantics/openAccessAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/http://purl.org/coar/access_right/c_abf2https://www.researchgate.net/publication/299592776_Blood-Pressure_Lowering_in_Intermediate-Risk_Persons_without_Cardiovascular_Disease/link/59d8ac87aca272e60966b4a5/downloadBlood pressureIntermediate riskCardiovascular diseaseBlood-pressure lowering in intermediate-risk persons without cardiovascular diseaseArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85PublicationTHUMBNAILBlood-pressure lowering in intermediate-risk persons without cardiovascular disease.pdf.jpgBlood-pressure lowering in intermediate-risk persons without cardiovascular disease.pdf.jpgGenerated Thumbnailimage/jpeg1781https://repositorio.udes.edu.co/bitstreams/2dfdd078-547a-49ed-a199-2bb0dfea746d/download6f2b0454df879634c8df8fd9f2bcdddfMD56TEXTBlood-pressure lowering in intermediate-risk persons without cardiovascular disease.pdf.txtBlood-pressure lowering in intermediate-risk persons without cardiovascular disease.pdf.txtExtracted texttext/plain56747https://repositorio.udes.edu.co/bitstreams/6b90f20d-22af-41b5-a317-795605083901/downloade6c9fb91069534fe8746cdcd3e97030cMD55ORIGINALBlood-pressure lowering in intermediate-risk persons without cardiovascular disease.pdfBlood-pressure lowering in intermediate-risk persons without cardiovascular disease.pdfapplication/pdf257373https://repositorio.udes.edu.co/bitstreams/3be78a2a-91e0-4a5a-ab0f-9508809adc3b/downloadd4139a8a1251680824766d09c1a0e5fdMD57LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/7bf7c2bf-4a8b-4a1e-8155-8d3a90f786eb/download38d94cf55aa1bf2dac1a736ac45c881cMD53001/3457oai:repositorio.udes.edu.co:001/34572023-10-10 08:40:55.097https://creativecommons.org/licenses/by-nc/4.0/Derechos Reservados - New England Journal of Medicine, 2016https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo= |